自拟通芪汤治疗原发性支气管肺癌104例

Tongqi Decoction for Treatment of Primary Bronchial Lung Cancer 104 cases

[目的]观察自拟方通芪汤治疗原发性支气管肺癌的临床疗效。[方法]将169例原发性支气管肺癌患者随机分为两组,治疗组104例,给予口服通芪汤治疗,对照组65例,给予口服消癌平片治疗,连服3个月后比较疗效。[结果]治疗组治疗后,瘤体缓解率75.96%,临床症状改善率85.58%,对照组治疗后,瘤体缓解率66.15%,临床症状改善率75.38%,两组疗效比较,差异有显著性(P<0.01)。[结论]自拟方通芪汤疗效显著,且无毒副作用。

[ Objective ] To observe the clinical efficacy of the treatment of primary bronchogenic carcinoma Tongqi decoction. [ Methods ] 169 cases of primary lung cancer patients were randomly divided into two groups, treatment group, 104 cases, given Tongqi decoction therapy treatment control group （65 cases） , to give oral Xiao Ai Ping Plan treatment, and even service the comparative efficacy of three months after. [ Re- sults ~ treatment group after treatment , tumor response rate of 75.96% clinical improvement rate of 85.58% in the control group , tumor response rate of 66.15% clinical improvement rate of 75.38% , the two groups, the difference was significant （P 〈0.01）. [ Conclusion] Tongqi decoction significant effect, and non -toxic side effects.